Research work · 2012
Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research